“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
Abstract Emulsion adjuvants such as MF59 and AS03 have been used for more than two decades as key components of licensed vaccines, with over 100 million doses administered to diverse populations in more than 30 countries. Substantial clinical experience of effectiveness and a well-established safety...
Main Authors: | Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-12-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00418-0 |
Similar Items
-
Author Correction: “World in motion” – emulsion adjuvants rising to meet the pandemic challenges
by: Derek T. O’Hagan, et al.
Published: (2023-02-01) -
A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated with a Recombinant Cytomegalovirus (CMV) Pentamer Antigen in Mice
by: Rushit N. Lodaya, et al.
Published: (2023-01-01) -
Aluminum Adjuvants—‘Back to the Future’
by: Donatello Laera, et al.
Published: (2023-07-01) -
The scientific journey of a novel adjuvant (AS37) from bench to bedside
by: Ugo D’Oro, et al.
Published: (2024-02-01) -
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
by: Carolin Loos, et al.
Published: (2023-03-01)